WINNERS & LOSERS: Vanquis cuts outlook; Zoo Digital loss narrows
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Thursday. Read More
| Price | 5.25p on 06-08-2026 at 18:25:04 |
|---|---|
| Change | 0.25p 5% |
| Buy | 5.50p |
| Sell | 5.00p |
| Last Trade: | Buy 22,500.00 at 5.308p |
| Day's Volume: | 1,058,001 |
| Last Close: | 5.25p |
| Open: | 5.10p |
| ISIN: | GB00B02LCQ05 |
| Day's Range | 5.10p - 5.50p |
| 52wk Range: | 5.00p - 12.10p |
| Market Capitalisation: | £332.46m |
| VWAP: | 5.049736p |
| Shares in Issue: | 6.33b |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Allergy Thera. (AGY) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 22,500 | 5.308p | Ordinary |
13:51:53 - 06-Aug-26 |
| Buy* | 10,000 | 5.30p | Ordinary |
13:51:15 - 06-Aug-26 |
| Buy* | 11,303 | 5.308p | Ordinary |
13:48:24 - 06-Aug-26 |
| Buy* | 2,000 | 5.315p | Ordinary |
13:00:02 - 06-Aug-26 |
| Buy* | 13,400 | 5.50p | Suspected BUY Trade |
11:00:00 - 06-Aug-26 |
| Unknown* | 400,000 | 5.00p | Negotiated Trade |
09:39:21 - 06-Aug-26 |
| Unknown* | 400,000 | 5.00p | Negotiated Trade |
09:38:54 - 06-Aug-26 |
| Buy* | 2,000 | 5.3245p | Ordinary |
09:37:35 - 06-Aug-26 |
| Buy* | 2,000 | 5.3245p | Ordinary |
09:33:36 - 06-Aug-26 |
| Buy* | 375 | 5.3245p | Ordinary |
09:03:26 - 06-Aug-26 |
Allergy Thera. (AGY) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 29th Jul 2026 7:00 am | RNS | Trading update for the year ended 30 June 2026 |
| 28th Jul 2026 7:00 am | RNS | Appointment of Executive Chairman |
| 30th Jun 2026 7:00 am | RNS | Vesting of Options under Long-Term Incentive Plan |
| 15th Jun 2026 7:00 am | RNS | Long Term Incentive Awards |
| 12th Jun 2026 7:00 am | RNS-R | Allergy Therapeutics to present at EAACI 2026 |
| 31st Mar 2026 7:00 am | RNS | Interim Results for six months ended 31 Dec 2025 |
| 12th Mar 2026 7:00 am | RNS | PDMR Dealings & Shareholding Update |
| 12th Mar 2026 7:00 am | RNS | PDMR Dealings & Shareholding Update |
| 4th Mar 2026 7:00 am | RNS | Positive Biomarker Results from PROTECT Trial |
| 26th Feb 2026 7:00 am | RNS-R | Allergy Therapeutics presents progress at AAAAI |